UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000023602
Receipt number R000027174
Scientific Title A prospective observation study of carbon-ion radiotherapy and concurrent S-1 chemotherapy for locally advanced pancreatic cancer (GUNMA1501)
Date of disclosure of the study information 2016/08/12
Last modified on 2021/08/16 10:45:06

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A prospective observation study of carbon-ion radiotherapy and concurrent S-1 chemotherapy for locally advanced pancreatic cancer (GUNMA1501)

Acronym

Carbon-ion radiation therapy with S-1 for Locally advanced pancreatic cancer

Scientific Title

A prospective observation study of carbon-ion radiotherapy and concurrent S-1 chemotherapy for locally advanced pancreatic cancer (GUNMA1501)

Scientific Title:Acronym

Carbon-ion radiation therapy with S-1 for Locally advanced pancreatic cancer

Region

Japan


Condition

Condition

Locally advanced pancreatic cancer

Classification by specialty

Radiology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

Evaluation the safety and effectiveness of carbon-ion radiation therapy with S-1 for locally advanced pancreatic cancer

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

2 year overall survival rate

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine Device,equipment

Interventions/Control_1

Carbon-ion radiation therapy. 55.2Gy(RBE)/12fractions/3weeks
S-1 80mg/m2/day 4weeks

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

80 years-old >=

Gender

Male and Female

Key inclusion criteria

1) Histlogical diagnosed invasive pancreatic cancer
2) without gastric ulcer
3) T stage is T4 (UICC 7th)
4) without direct invasion to GI tract
5) patient age is between 20 to 80 years old
6) performance status is 0-2
7) No history of surgery or irradiation for pancreatic cancer

Key exclusion criteria

1) direct invasion to GI truct
2) visivle ascites
3) use of metalic billiary stent
4) use of Flucytosine, phenytoin or warfarin
5) active scar or infection within the irradiation area
6) severe co-occurring disorders (diabetes mellitus, heart failure and so on)
7) co-occurring malignancies
8) Chemotherapy history over 3 month
9) History of irradiation to the irradiating area

Target sample size

20


Research contact person

Name of lead principal investigator

1st name Tatsuya
Middle name
Last name Ohno

Organization

Gunma University

Division name

Gunma University Heavy Ion Medical Center

Zip code

371-8511

Address

3-39-22 Showa, Maebashi, Gunma

TEL

027-220-8378

Email

tohno@gunma-u.ac.jp


Public contact

Name of contact person

1st name Masahiko
Middle name
Last name Okamoto

Organization

Gunma University

Division name

Gunma University Heavy Ion Medical Center

Zip code

371-8511

Address

3-39-22 Showa, Maebashi, Gunma

TEL

027-220-8378

Homepage URL


Email

okamott@gunma-u.ac.jp


Sponsor or person

Institute

Gunma University Heavy Ion Medical Center

Institute

Department

Personal name



Funding Source

Organization

Gunma University Heavy Ion Medical Center

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Gunma University Hospital Clinical Research Review Board

Address

3-39-22 Showa Maebashi

Tel

027-220-8740

Email

gunmaciru-office@umin.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2016 Year 08 Month 12 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2015 Year 07 Month 22 Day

Date of IRB

2015 Year 10 Month 28 Day

Anticipated trial start date

2015 Year 11 Month 01 Day

Last follow-up date

2024 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2016 Year 08 Month 12 Day

Last modified on

2021 Year 08 Month 16 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000027174


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name